Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma

Published:2023-01-02 Issue:1 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Bersanelli Melissa¹^ORCID,Rebuzzi Sara Elena²³,Roviello Giandomenico⁴,Catalano Martina⁴,Brunelli Matteo⁵,Rizzo Mimma⁶

Affiliation:

1. Medical Oncology Unit, University Hospital of Parma, Parma, Italy

2. Medical Oncology Unit, Ospedale San Paolo, Savona, Italy

3. Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy

4. Department of Health Sciences, University of Florence, Florence, Italy

5. Department of Pathology, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, Verona, Italy

6. Medical Oncology Unit, Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Bari, Italy

Funder

no funding

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2171672

Reference36 articles.

1. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours

2. Sarcomatoid Differentiation in Renal Cell Carcinoma

3. Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade

4. Systemic Therapy for Non–Clear Cell Renal Cell Carcinoma

5. Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma;Modern Pathology;2024-09

2. Clinical outcome predictors for metastatic renal cell carcinoma: a retrospective multicenter real-life case series;BMC Cancer;2024-07-05

3. First-Line Treatments and Management of Metastatic Renal Cell Carcinoma Patients: An Italian Interdisciplinary Uro-Oncologic Group Algorithm;Cells;2024-06-02

4. Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of “palateau”;Human Vaccines & Immunotherapeutics;2024-05-17

5. Emerging roles of MITF as a crucial regulator of immunity;Experimental & Molecular Medicine;2024-02-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3